Viking Therapeutics, INC. (VKTX) — SC 13G/A Filings
All SC 13G/A filings from Viking Therapeutics, INC.. Browse 9 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (9)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Oct 18, 2024
- SC 13G/A Filing — Aug 7, 2024
- SC 13G/A Filing — Feb 14, 2024
-
FMR LLC & Abigail Johnson Report 14.999% Stake in Viking Therapeutics
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its Chairman and CEO, Abigail P. Johnson, have updated their ownership stake in Viking Therapeutics, Inc. (VKNG) through a -
State Street Corp. Amends Viking Therapeutics Stake Disclosure
— Jan 24, 2024
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 24, 2024, indicating its ownership of Viking Therapeutics Inc. com -
Millennium Management Updates VKTX Stake as of Dec 31, 2023
— Jan 12, 2024
Millennium Management LLC, a Delaware-based investment firm, filed an amended SC 13G/A on January 12, 2024, disclosing its holdings in Viking Therapeutics, Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX